Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1AMINO GmbH
01 1Betaine Anhydrous
02 1Betaine anhydrous
01 1Germany
02 1India
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-076
Start Marketing Date : 2024-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46052-0196
Start Marketing Date : 1997-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
94
PharmaCompass offers a list of Betaine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betaine manufacturer or Betaine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betaine manufacturer or Betaine supplier.
PharmaCompass also assists you with knowing the Betaine API Price utilized in the formulation of products. Betaine API Price is not always fixed or binding as the Betaine Price is obtained through a variety of data sources. The Betaine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Additive Screening Solution 40/Fluka kit no 78374 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Additive Screening Solution 40/Fluka kit no 78374, including repackagers and relabelers. The FDA regulates Additive Screening Solution 40/Fluka kit no 78374 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Additive Screening Solution 40/Fluka kit no 78374 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Additive Screening Solution 40/Fluka kit no 78374 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Additive Screening Solution 40/Fluka kit no 78374 supplier is an individual or a company that provides Additive Screening Solution 40/Fluka kit no 78374 active pharmaceutical ingredient (API) or Additive Screening Solution 40/Fluka kit no 78374 finished formulations upon request. The Additive Screening Solution 40/Fluka kit no 78374 suppliers may include Additive Screening Solution 40/Fluka kit no 78374 API manufacturers, exporters, distributors and traders.
click here to find a list of Additive Screening Solution 40/Fluka kit no 78374 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Additive Screening Solution 40/Fluka kit no 78374 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Additive Screening Solution 40/Fluka kit no 78374 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Additive Screening Solution 40/Fluka kit no 78374 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Additive Screening Solution 40/Fluka kit no 78374 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Additive Screening Solution 40/Fluka kit no 78374 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Additive Screening Solution 40/Fluka kit no 78374 suppliers with NDC on PharmaCompass.
We have 2 companies offering Additive Screening Solution 40/Fluka kit no 78374
Get in contact with the supplier of your choice:
